Del. Justices Uphold $275M AstraZeneca Drug Trial Debt Toss
Delaware's Supreme Court on Thursday upheld without elaboration a Chancery Court finding that cleared AstraZeneca PLC of liability for $275 million in post-merger cancer drug development "milestone" payments to investors in...To view the full article, register now.
Already a subscriber? Click here to view full article